Peri-operative morbidity and mortality related to radical cystectomy: A multi-institutional retrospective study in Japan

BJU International

Volumn 110, Issue 11 B, 2012, Pages

  Takada, Norikata ^a   Abe, Takashige ^a   Shinohara, Nobuo ^a   Sazawa, Ataru ^a   Maruyama, Satoru ^a   Shinno, Yuichiro ^b   Sato, Soshu ^b   Mitsuhashi, Kimiyoshi ^b   Sato, Takuya ^b   Sugishita, Keiji ^b   Kamota, Shinji ^b   Yamashita, Takanori ^b   Ishizaki, Junji ^b   Hioka, Takaya ^b   Mouri, Gaku ^b   Ono, Takenori ^b   Miyajima, Naoto ^b   Sakuta, Takanori ^b   Mochizuki, Tango ^b   Aoyagi, Toshiki ^b   Katano, Hidenori ^b   Akino, Tomoshige ^b   Hirakawa, Kazushi ^b   Minami, Keita ^b   Kumagai, Akira ^b   Seki, Toshimori ^b   Togashi, Masaki ^b   Nonomura, Katsuya ^a   more..

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hokkaido Urothelial Cancer Research Group   (Japan)

Author keywords

Complication; Morbidity; Mortality; Radical cystectomy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CARDIOVASCULAR DISEASE; COMORBIDITY; CYSTECTOMY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; ILEAL CONDUIT; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; URINARY DIVERSION; UROGENITAL TRACT DISEASE; WOUND HEALING IMPAIRMENT; BLADDER TUMOR; COMPARATIVE STUDY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PERIOPERATIVE PERIOD; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; MORBIDITY; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

MLCS; MLOWN;

EID: 84876424827     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11609.x     Document Type: Article

References (30)

1. Soulié M, Straub M, Gamé X et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol 2002 ; 167 : 1325-8
2. Novotny V, Hakenberg OW, Wiessner D et al. Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 2007 ; 51 : 397-402
3. Svatek RS, Fisher MB, Matin SF et al. Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol 2010 ; 183 : 929-34
4. Bostrom PJ, Kossi J, Laato M et al. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2009 ; 103 : 191-6
5. Chang SS, Cookson MS, Baumgartner RG et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002 ; 167 : 2012-6
6. Hollenbeck BK, Miller DC, Taub D et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005 ; 174 : 1231-7
7. Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology 2006 ; 68 : 58-64
8. Lowrance WT, Rumohr JA, Chang SS et al. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol 2008 ; 179 : 1313-8
9. Shabsigh A, Korets R, Vora KC et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009 ; 55 : 164-74
10. Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol 2010 ; 184 : 990-4
11. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996 ; 93 : 2212-45
12. Japanese Circulation Society. Guidelines for the diagnosis,treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2004). J Cardiol 2005 ; 45 : 349-66
13. Matsumoto T, Kiyota H, Matsukawa M et al. Japanese guidelines for prevention of perioperative infections in urological field. Int J Urol 2007 ; 14 : 890-909
14. Fearon KC, Ljungqvist O, Von Meyenfeldt M et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005 ; 24 : 466-77
15. Donat SM. Standards for surgical complication reporting in urologic oncology: time for a change. Urology 2007 ; 69 : 221-5
16. Kubo M, Kiyohara Y, Kato I et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003 ; 34 : 2349-54
17. Kitabatake A. Guidelines for the primary prevention of ischemic heart disease revised version. Circ J Suppl 2006 ; 1-9
18. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. A m Heart J 1986 ; 111 : 383-90
19. Wolf PA, D'Agostino RB, Kannel WB et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988 ; 259 : 1025-9
20. Iwai A, Koga F, Fujii Y et al. Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy. Jpn J Clin Oncol 2011 ; 41 : 1373-9
21. Pycha A, Comploj E, Martini T et al. Comparison of complications in three incontinent urinary diversions. Eur Urol 2008 ; 54 : 825-32
22. Kilciler M, Bedir S, Erdemir F et al. Comparison of ileal conduit and transureteroureterostomy with ureterocutaneostomy urinary diversion. Urol Int 2006 ; 77 : 245-50
23. Barbieri CE, Lee B, Cookson MS et al. Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol 2007 ; 178 : 1418-21
24. Ikeda N, Saito E, Kondo N et al. What has made the population of Japan healthy? Lancet 2011 ; 378 : 1094-105
25. Grossman H, Natale R, Tangen C et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003 ; 349 : 859-66
26. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005 ; 48 : 202-5
27. Shariat SF, Karakiewicz PI, Palapattu GS et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006 ; 176 : 2414-22
28. Yafi FA, Aprikian AG, Chin JL et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int 2011 ; 108 : 539-45
29. von der Maase H, Hansen SW, Roberts JT et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000 ; 18 : 3068-77
30. Dash A, Pettus JA, Herr HW et al. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer 2008 ; 113 : 2471-7